Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Julia F, Slejko"'
Publikováno v:
BMJ Open Quality, Vol 13, Iss 3 (2024)
Background The US Food and Drug Administration (FDA) issued a warning in December 2018 regarding an increased risk of aortic aneurysms and aortic dissections associated with fluoroquinolone (FQ) use. This warning specifically targeted older adults an
Externí odkaz:
https://doaj.org/article/235b3ac095d04df9a1d3f45204173fe8
Autor:
Chengchen Zhang, Zafar Zafari, Julia F. Slejko, Wendy Camelo Castillo, Gloria M. Reeves, Susan dosReis
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2023)
IntroductionDespite considerable investment in suicide prevention since 2001, there is limited evidence for the effect of suicide prevention interventions among children and adolescents. This study aimed to estimate the potential population impact of
Externí odkaz:
https://doaj.org/article/1159d5bbe83044bfbbb1f19ae2873ee2
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-12 (2020)
Abstract Background There are limited data on economic aspects of the genetic variant of chronic obstructive pulmonary disease (COPD) in the context of the more prevalent form of COPD. The objective of this study was to isolate the healthcare resourc
Externí odkaz:
https://doaj.org/article/b23ca39c6d914ba988e24ae757429922
Autor:
Daisuke Goto, Rahul Khairnar, Jean A. Yared, Candice Yong, Dorothy Romanus, Eberechukwu Onukwugha, Julia F. Slejko
Publikováno v:
Cancer Medicine, Vol 9, Iss 2, Pp 626-639 (2020)
Abstract The landscape of treatment for multiple myeloma (MM) has significantly changed over the last decade due to novel agents that have shown superiority in efficacy such as proteasome inhibitors (PIs) and immunomodulatory drugs (IMiDs) over tradi
Externí odkaz:
https://doaj.org/article/c2dcfdfc6c454f1680acb8474f5a49ea
Publikováno v:
Rheumatology and Therapy, Vol 6, Iss 4, Pp 611-616 (2019)
Abstract Introduction Pain control is one of the most important aspects of rheumatoid arthritis (RA) management from the patient’s perspective. Newer generations of RA treatment including tumor necrosis factor inhibitor (TNFi) have the potential to
Externí odkaz:
https://doaj.org/article/7fb7adf40af441ca895db4944824846e
Autor:
Erin G. Roth, Justin Kim, Julia F. Slejko, C. Daniel Mullins, Jennifer L. Doyle, David L. Levitt, Miguel Melendez, Kyle J. Fletke, Yinin Hu
Publikováno v:
The Patient - Patient-Centered Outcomes Research. 16:67-76
Autor:
Susan dosReis, Laura M. Bozzi, Beverly Butler, Richard Z. Xie, Richard H. Chapman, Jennifer Bright, Erica Malik, Julia F. Slejko
Publikováno v:
The Patient - Patient-Centered Outcomes Research. 16:57-66
Autor:
Justin Kim, Erin G. Roth, Kendyl Carlisle, Kashif M. Munir, Kyle J. Fletke, Julia F. Slejko, C. Daniel Mullins, Yinin Hu
Publikováno v:
Endocrine Practice.
Autor:
Allison L Hollis, Ashleigh V Lowery, Mehrnaz Pajoumand, Si M Pham, Julia F Slejko, Kenichi A Tanaka, Michael Mazzeffi
Publikováno v:
Annals of Cardiac Anaesthesia, Vol 19, Iss 3, Pp 418-424 (2016)
Background: Cardiac transplantation can be complicated by refractory hemorrhage particularly in cases where explantation of a ventricular assist device is necessary. Recombinant activated factor VII (rFVIIa) has been used to treat refractory bleeding
Externí odkaz:
https://doaj.org/article/8d927520ec21463195e09aaef4625cf0
Autor:
Hilary Hayssen, Shalini Sahoo, Phuong Nguyen, Minerva Mayorga-Carlin, Tariq Siddiqui, Brian Englum, Julia F Slejko, C. Daniel Mullins, Yelena Yesha, John D Sorkin, Brajesh K Lal
Publikováno v:
medRxiv
BackgroundVenous thromboembolism (VTE) is a preventable complication of hospitalization. Risk-stratification is the cornerstone of prevention. The Caprini and Padua are the most commonly used risk-assessment models to quantify VTE risk. Both models p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a6bad0efcb499eceee5c64001a207f4
https://doi.org/10.1101/2023.03.20.23287506
https://doi.org/10.1101/2023.03.20.23287506